ReviewiScience2026
Idiopathic pulmonary fibrosis from a multiscale mechanobiology perspective: Mechanisms and future therapeutic prospects.
Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease that induces irreversible fibrosis and architectural remodeling. Traditional inflammation-based theories fall short in explaining its pathological processes, regional heterogeneity, and spatially biased lesion distribution. Recent studies have highlighted the critical role of biomechanical microenvironment, ranging from the molecular and cellular level to the whole-organ scale, in driving fibrotic progression. This review adopts a multiscale biomechanical perspective for understanding IPF pathogenesis, integrating molecular, cellular, tissue, and organ-level mechanisms. We summarize recent advances in IPF research from five key biomechanical perspectives: mechanotransduction, mechanical memory, extracellular matrix (ECM) stiffening, strain-induced fibroblast activation, and the spatial propagation of fibrosis. We further explore therapeutic strategies targeting mechanical signaling pathways and discuss the integration of machine learning and physics-informed neural networks (PINNs) for interpretable, physiology-constrained modeling. This review aims to provide a new mechanobiological perspective for understanding and intervening in IPF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.